SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

BrokeCoin is a meme-meets-utility cryptocurrency project operating under the ethos of Transparency, Community, and Respect. Formally registered as an LLC in Wyoming, USA, BrokeCoin is building an expansive ecosystem that combines light-hearted spirit of meme culture with real-world crypto utilities—spanning gaming, staking, NFTs, web services, and an e-commerce platform. Brokecoin believes in developing useful and interesting meme-inspired utilities to both service the crypto industry, and generate value for holders.

Brokecoin

Brokecoin is trending as the community rallies around upcoming utilities, P2E Telegram games, and weekly contests to reward holders. Discussions highlight a potential token burn event at 2500 watchers, alongside the coin's resilience as a Solana survivor meme coin. Community members emphasize active development and ongoing efforts to engage and reward the "Spare Change Army".

GME Ethereum

GME Ethereum is trending as the community anticipates a "God Candle" and a tweet from Roaring Kitty, potentially signaling a major surge. Discussions also revolve around JTR Crypto (JTRAMBO) and its recent market cap milestones, with community members emphasizing a "buy and hold" strategy. However, some users are raising concerns about the legitimacy of the project and its affiliation with GameStop.

BENQI is a decentralized non-custodial liquidity market protocol, built on Avalanche. The protocol enables users to effortlessly lend, borrow, and earn interest with their digital assets. Depositors providing liquidity to the protocol may earn passive income, while borrowers are able to borrow in an over-collateralized manner.

Benqi Finance

Benqi Finance is trending as community members highlight its potential within the Avalanche network, noting its fully diluted supply and predictions of significant influx of RWAs; the overall sentiment suggests a possible run. Some users point to Forbes coverage and increasing TVL as reasons for optimism, while others focus on tokenomics and compare it to other DeFi projects.

CEL-SCI Corp. is a clinical-stage biotechnology company, which engages in the research, development, and manufacture of investigational immunotherapy products for the treatment of cancer and infectious diseases. Its product pipeline includes Multikine and Ligand Epitope Presentation System (LEAPS). Multikine is an investigational immunotherapy for the potential treatment of head and neck cancers. LEAPS is categorized into LEAPS-H1N1-DC, a product candidate for the treatment of pandemic influenza for hospitalized patients and CEL-2000 and CEL-4000, which are vaccine candidates for the treatment of rheumatoid arthritis. The company was founded by Maximilian de Clara on March 22, 1983 and is headquartered in Vienna, VA.

Cel-Sci Corp.

Cel-Sci is trending as community members anticipate news regarding a potential partnership with Dallah Pharma and the related SFDA application for Multikine, an immunotherapy treatment. The community expresses optimism about Multikine's potential in the Saudi Arabian market, aligning with Saudi Vision 2030, but also discusses the company's history and possible future dilution. Chatter revolves around potential catalysts and speculation about a short squeeze.

$WAGMI is a community-driven meme token built on the Solana blockchain, designed to bring positivity, unity, and humor into the crypto space. The project encourages community engagement through memes, social interaction, and token-based activities. It leverages Solana’s fast and low-cost infrastructure to allow for smooth on-chain interactions, such as token transfers, community games, and NFT integration. The goal is to foster a fun, inclusive ecosystem where holders feel they are part of a larger movement – "We Are Gonna Make It."

WAGMI

WAGMI is trending as the community rallies around positive sentiment and long-term holding, emphasizing the "WAGMITHON" and strong community support. The community is speculating about a potential CMC listing while highlighting the token's solid liquidity and cultural appeal within the $SOL ecosystem. Discussions also focus on the project's doxxed team and consistent growth.

FLOKI is the utility token of the Floki Ecosystem. The Floki Ecosystem is a community-powered ecosystem that aims to give people control of their finances through four key utility offerings:  - The Valhalla NFT Metaverse Game. - The Floki University Crypto Education platform. - DeFi. - The FlokiPlaces NFT & Merchandise Marketplace.

Floki Token

Floki is trending as the token was recently listed on Robinhood, though some traders are noting a lack of immediate price surge following the news. Community members are discussing potential catalysts, including the Valhalla game tournament and burn mechanisms, while also comparing Floki's potential to other meme coins like Dogecoin and Shiba Inu during the anticipated altcoin season.

Epsium Enterprise Ltd. operates as a holding company, which engages in import trading and distribution of wines and spirits. It offers a range of products, including Chinese liquor, French cognac, Scottish whisky, fine wines, champagne, and other miscellaneous alcoholic beverages. Its brands include Moutai, Xijiu, Wuliangye, Remy Martin Cognac, Macallan, Cointreau, Piper Heidsieck Champagne, French Fine Wines, Red and White Wines. The company was founded by Son I Tam on March 24, 2020 and is headquartered in Macau.

Epsium Enterprise Ltd. - Ordinary Shares - Class A

Epsium Enterprise Ltd.

Epsium Enterprise (EPSM) is trending due to its volatile price action and potential short squeeze, attracting both bullish and bearish speculation. Community discussions revolve around the stock's low float and comparisons to other recent IPOs that have experienced significant price movements. Some traders are also wary of EPSM, with concerns about a potential pump-and-dump scheme due to its association with other Chinese stocks.

Joby Aviation, Inc. is a transportation company, which engages in developing an all-electric, vertical take-off and landing aircraft that intends to operate as a commercial passenger aircraft. The company was founded by Bevirt Joebenn in 2009 and is headquartered in Santa Cruz, CA.

Joby Aviation Inc

Joby Aviation ($JOBY) is trending amid discussions about its potential participation in the White House's eVTOL Integration Pilot Program and broader market sentiment on pre-revenue companies. While some community members express concerns over valuation and cash burn, others highlight the company's partnerships and progress towards FAA certification, viewing it as a leader in the emerging eVTOL market. Bullish sentiment is fueled by potential catalysts like commercial launches and government support.

Green Satoshi Token

GSTSOL is gaining attention as traders discuss its potential for a significant breakout, with some pointing to technical indicators and increasing volume as bullish signals. The community is closely watching for a catalyst that could trigger a rally, while also considering factors like its low market cap and past performance. Sentiment is mixed, with some expressing frustration over previous price action and others remaining optimistic about future gains.

Ucore Rare Metals, Inc. Is a technology company, which engages in the business of metal separation products, and services to the mining and mineral extraction industry. Its projects include Bokan-Dotson Ridge Rare Earth Element. The company was founded on October 5, 2006 and is headquartered in Halifax, Canada.

Ucore Rare Metals Inc

Ucore Rare Metals Inc.

Ucore Rare Metals ($UURAF) is trending due to community excitement around its strategic partnerships, particularly with Critical Metals ($CRML), and government funding for its rare earth processing facility in Louisiana. Investors are optimistic about Ucore's potential to benefit from increasing demand for domestic rare earth element production and its proprietary RapidSX technology. Community members speculate about future government deals, exchange uplisting, and potential customer agreements, contributing to the stock's recent momentum.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Wall Street Analysts Believe GH Research (GHRS) Could Rally 107.25%: Here's is How to Trade

The average of price targets set by Wall Street analysts indicates a potential upside of 107.3% in GH Research (GHRS). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

These five health care stocks, all belonging to small- or micro-cap categories, notched the highest jump in Stocktwits followers in the week ended Feb. 7, 2025:GH Research PLC (+103% jump in followers)&nbsp;GH Research PLC focuses on developing mebufotenin-based therapies for treatment-resistant depression. The company’s inhalable candidate, GH001, met its primary endpoint in a Phase 2b trial, showing a significant reduction in depression scores compared to placebo. Secondary endpoints also showed improvements, with no serious adverse events reported.&nbsp;Despite the promising data, GHRS stock fell more than 28% over the past week.Lipella Pharmaceuticals Inc. (+40% jump in followers)Lipella Pharmaceuticals received FDA approval for an Expanded Access Program for LP-310, an oral rinse for treating oral lichen planus. The condition affects around 6 million Americans and currently has no FDA-approved therapies. The program allows patients with serious unmet medical needs to access the treatment outside of clinical trials.&nbsp;Following the announcement, LIPO stock climbed nearly 14% last week.MBX Biosciences Inc. (+39% jump in followers)MBX Biosciences, focused on peptide therapies for endocrine and metabolic disorders, had no major catalyst last week. However, in January, the company reported positive results from a Phase 1 trial of its long-acting GLP-1 receptor antagonist, MBX 1416, which showed a favorable safety profile.&nbsp;MBX shares surged more than 25% over the past week.Rani Therapeutics Holdings Inc. (+29% jump in followers)Rani Therapeutics, which is developing oral alternatives to injectable biologics, shared new preclinical data on its RaniPill capsule for delivering semaglutide. The study showed successful drug delivery with bioavailability and weight-loss effects comparable to subcutaneous administration. The company plans to start Phase 1 trials of a GLP-1/GLP-2 dual agonist in 2025.&nbsp;RANI stock rose over 12% last week.Invivyd Inc. (+21% jump in followers)Invivyd, which focuses on monoclonal antibodies for viral diseases, reported positive data from its ongoing Phase 1/2 trial of VYD2311, a potential alternative to COVID-19 vaccines. The candidate showed strong antiviral activity and a promising safety profile. The data, combined with results from its Phase 3 CANOPY trial, support its potential as a long-acting COVID-19 treatment.&nbsp;Invivyd shares soared over 355% last week.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Woman examining laboratory samples - stock photo | Image source: Getty Images

These 5 Health Care Stocks Saw The Sharpest Retail Interest Jump Last Week

These five small-cap pharma and biotech stocks drew heavy attention on Stocktwits last week, driven by key trial results, FDA updates, and promising drug developments.

Equity

GH Research (NASDAQ:GHRS) Shares Gap Up to $10.30

GH Research PLC (NASDAQ:GHRS  Get Free Report) shares gapped up prior to trading on Thursday . The stock had previously closed at $10.30, but opened at $10.55. GH Research shares last traded...

GH Research (GHRS) Shares Cross Above 200 DMA

In trading on Tuesday, shares of GH Research PLC (GHRS) crossed above their 200 day moving average of 9.15, changing hands as high as 9.39 per share. GH Research PLC shares are currently...

GH Research (GHRS, $8.18) Aroon Indicator entered an Uptrend on March 07, 2024.

Over the last three days, A.I.dvisor has detected that GHRS's AroonUp green line (see chart) is above 70, while the AroonDown red line is below 30. When the green line goes above 70 while the red...

GH Research (NASDAQ:GHRS) Price Target Cut to $39.00 by Analysts at JMP Securities

GH Research (NASDAQ:GHRS  Free Report) had its price objective reduced by JMP Securities from $50.00 to $39.00 in a research note published on Friday morning, Benzinga reports. They currently...

GH Research price target lowered by $11 at JMP Securities, here's why

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

GH Research reports FY23 EPS (68c), consensus (67c)

GH Research Reports Full Year 2023 Financial Results and Provides Business Updates

Phase 2b clinical trial of GH001 in patients with treatment-resistant depression on track for expected completion of double-blind phase in Q3 2024Phase 2a clinical trial of GH001 in postpartum...

GH Research (GHRS, $8.55) entered Uptrend as Momentum indicator ascends above 0 level on Feb 27, 2024

This indicator may be signaling GHRS's price has momentum to move higher, since its current price moved above its price 14 days ago. Traders may consider buying the stock or exploring call options...

GH Research Plc operates as a holding company, which engages in the provision of biopharmaceutical products and services. It develops therapeutic products for patients of psychiatric and neurological disorders. The firm develops novel and proprietary 5-Methoxy-N and N-Dimethyltryptamine, or 5-MeO-DMT, therapies. The company was founded by Theis Terwey, Florian Schönharting, and Magnus Halle in 2018 and is headquartered in Dublin, Ireland.

GH Research PLC

Will PepsiCo ($PEP) beat quarterly earnings? 
 
*Powered by Polymarket

Stocktwits

PepsiCo Inc

) beat quarterly earnings? 
 
*Powered by Polymarket

Fiscal Period	Estimated	Reported	Surprise	Result
Q3 '25	-$0.23	--	--	N/A
Q2 '25	-$0.21	-$0.15	29.82%	BEAT
Q1 '25	-$0.37	-$0.19	47.95%	BEAT
Q4 '24	-$0.21	--	--	N/A
Q3 '24	-$0.25	-$0.23	6.50%	BEAT

GHRS
GH Research PLC

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q3 '25

Historical Earnings

Latest GHRS News

GHRS GH Research PLC